Our findings highlight an antidepressant effect by injection of IDO1 inhibitor into the DRN of mice and raise the possibility that IDO1 is involved in controlling depression in humans and may thus represent a novel drug target. This evidence concerns the gene IDO1 and depressive symptom measurement.